Dare Bioscience Inc. (DARE) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Dare Bioscience Inc. (DARE:NASDAQ), powered by AI.

Current Price
$2.87
P/E Ratio
-6.0
Market Cap
24M
Sector
Healthcare
What is the Dare Bioscience Inc. stock price forecast?

Dare Bioscience Inc. is currently trading at $2.87. View real-time AI analysis on Alpha Lenz.

What is Dare Bioscience Inc. insider trading activity?

View the latest insider trading data for Dare Bioscience Inc. on Alpha Lenz.

What is Dare Bioscience Inc.'s P/E ratio?

Dare Bioscience Inc.'s P/E ratio is -6.0.

Dare Bioscience Inc.

NASDAQ · DARE
$2.87
Ask about Dare Bioscience Inc.'s future dividend policy...
Alpha Chat Insight

Dare Bioscience Inc. trades at a P/E of -6.0 (undervalued) with strong ROE of 73.3%.

Ask for details

Company Overview

Dare Bioscience Inc. is a clinical-stage biopharmaceutical company dedicated to advancing healthcare opportunities in the field of women’s reproductive health. The primary focus of the company is to develop innovative products that address a variety of conditions and prioritize unmet needs in women's sexual health, with a range of initiatives targeting fertility, contraception, and vaginal health. Notable features of Dare Bioscience's portfolio include hormonal and non-hormonal therapies, inventive contraceptive solutions, and treatments for pelvic conditions. Operating within the dynamic biopharmaceutical sector, Dare Bioscience plays a significant role in fostering advancements through its partnership and research collaborations across the globe. The company’s strategic efforts aim to deliver both novel and effective healthcare solutions that potentially improve quality of life and generate impactful outcomes for women. Dare Bioscience's commitment to innovation highlights its market significance, as it seeks to address broad and underserved areas of women's health care.

CEOMs. Sabrina Martucci Johnson
SectorHealthcare
IndustryBiotechnology
Employees21

Company Statistics

FY 2024

Profile

$24.39MMarket Cap
$9.78KRevenue
0.00Shares Out
21Employees

Margins

N/AGross
-447552.49%EBITDA
-239692.20%Operating
-41430.90%Pre-Tax
-41430.90%Net

Valuation

-6.02P/E
-4.06P/B
2492.61EV/Sales
-0.23EV/EBITDA
5.06P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-18.69%ROA
73.30%ROE
-108.11%ROIC

Financial Health

$15.70MCash & Cash Equivalents
$12.42MNet Debt
-467.61%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Dare Bioscience Inc. (ticker: DARE) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 21 employees. Market cap is $24M.

The current price is $2.87 with a P/E ratio of -6.02x and P/B of -4.06x.

ROE is 73.30% and operating margin is -239692.20%. Annual revenue is $9,784.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Dare Bioscience Inc. (Healthcare) Stock Forecast & Analysis $2.87 | Alpha Lenz